4
Changes in Ownership
Avalyn Pharma Inc. Filed Acc 0001193125-26-201868
Options or other derivatives
- Chief Operating Officer acquired 211,975 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rhodes Melissa Chief Operating Officer | 2026-04-29 | Grant or award · Stock Option (Right to Buy) | +211,975 | 211,975 | D | ||
Loading xslF345X06/ownership.xml…